Inventor
DASGUPTA BIRESHWAR
US16 patents
Patents
16 patentsUS6888004B2May 3, 2005
Imidazolyl derivatives as corticotropin releasing factor inhibitors
BRISTOL MYERS SQUIBB CO7 citations71
US10669272B2Jun 2, 2020
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO4 citations70
US6939968B2Sep 6, 2005
Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives
BRISTOL MYERS SQUIBB CO6 citations67
US7238699B2Jul 3, 2007
Imidazolyl derivatives as corticotropin releasing factor inhibitors
BRISTOL MYERS SQUIBB CO3 citations62
US6239146B1May 29, 2001
Neurotrophic difluoroamide agents
BRISTOL MYERS SQUIBB CO2 citations62
US6096762AAug 1, 2000
Neurotrophic difluoroamide agents
BRISTOL MYERS SQUIBB CO4 citations62
US11713316B2Aug 1, 2023
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations59
US11166959B2Nov 9, 2021
Isofuranone compounds useful as HPK1 inhibitors
BRISTOL MYERS SQUIBB CO1 citations59
US10954238B1Mar 23, 2021
Substituted naphthyridinone compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations59
US7211669B2May 1, 2007
Imidazolyl derivatives as corticotropin releasing factor inhibitors
BRISTOL MYERS SQUIBB CO2 citations59
US9932320B2Apr 3, 2018
Quinoline-based kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US11584747B2Feb 21, 2023
Substituted pyridopyrimidinonyl compounds useful as T cell activators
BRISTOL MYERS SQUIBB CO0 citations48
US9598423B2Mar 21, 2017
Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitors
BRISTOL MYERS SQUIBB CO0 citations45
US9273058B2Mar 1, 2016
Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitors
BRISTOL MYERS SQUIBB CO1 citations45
US10035777B2Jul 31, 2018
Heterocyclic kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations41
US9737542B2Aug 22, 2017
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations41